Select Page

Chennai April 23, 2020: Medall Diagnostics, a leading integrated diagnostic services provider, today announced the receipt of approval from the Indian Council of Medical Research (ICMR) for conducting COVID-19 tests. With a new 15,000 square feet central reference lab at Guindy in Chennai, equipped with state of the art equipment, Medall has the capacity to process close to 1000 samples every day, positioning it as amongst the largest COVID-19 testing providers in the state.
Speaking on the approval received last evening, Arjun Ananth, CEO, Medall, said “There is an urgent need to bring in more and more private laboratories for testing the samples. Reliable testing to screen for the disease is becoming increasingly apparent. As a quality focused, integrated diagnostic service provider, Medall is uniquely placed to meet the growing demand for reliable and quick testing of Coronavirus samplesusing the standard, state-of-the-art Real Time Polymerise Chain Reaction (RTPCR) testing methodology. We also look forward to working closely with the Government of Tamilnadu to enhance its testing capacity further”.
Priced at Rs. 4,000 per test, bookings for the test can be done online at or by calling 75501 77777
About Medall:
Medall is India’s fastest growing integrated Healthcare Diagnostics and the fourth largest Diagnostics player in India. With 7000 plus customer touch points in 9 states and 70+ districts, 24 NABL accredited labs and 108 ISO Certified Labs, Medall provides both radiology and pathology services under one roof. Medall has served over 10 million customers and performed over 30 million tests in 2018. With a strong focus on digitisation and deployment of state-of-the-art technology, Medall is pioneering clinical and technological innovations in Diagnostics. To know more please log on to:
For media enquiries, please contact: Santosh: PRHUB / +91-78927-72953 /